Howard Burman, Ph.D, CHIEF EXECUTIVE OFFICER & & Chairman of Coya Therapy Inc COYA, attended on Benzinga’s All Accessibility.
Coya is a clinical-stage biotechnology firm concentrated on establishing exclusive brand-new treatments to boost the feature of regulative T cells. The firm is presently establishing multi-modality Treg treatments for neurodegenerative, autoimmune and also metabolic conditions.
Coya has actually just recently introduced favorable information from current and also continuous tests.
See the complete meeting right here:
Included picture by Hal Gatewood on Unsplash
This message has funded advertising and marketing web content. This web content is for informative functions just and also is not meant to be spending suggestions.
.
.(* ) © 2023 Benzinga.com. Benzinga does not supply financial investment suggestions. All legal rights scheduled.
